IQ Proteomics

Curated by Signal

Tandem Mass Tag based proteomics platform

Life Sciences Technologyiqproteomics.com

Overview

IQ Proteomics is commercializing technologies for quantitative multiplexed proteomics applications. The company offers solutions for discovery proteomics, post-translational modification analysis, and high throughput targeted assays based on its licensed Tandem Mass Tag (TMT) 10plex technology that enables simultaneous analysis of up to 10 samples.

Key facts

Founded: 2015
Headquarters: Boston, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

5 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

PREEMIEr Diagnostics
Developer of a device to measure the blood glucose level in premature infants
Life Sciences TechnologyUnited States
Gattaca Genomics
AI-powered platform offering genetic analysis services
Life Sciences TechnologyLauderdale, United States
Healid
Blockchain based-AI enabled platform to provide gene therapies
Life Sciences TechnologyBoise, United States

About IQ Proteomics

What does IQ Proteomics do?

IQ Proteomics is commercializing technologies for quantitative multiplexed proteomics applications.

Where is IQ Proteomics headquartered?

IQ Proteomics is headquartered in Boston, United States.

When was IQ Proteomics founded?

IQ Proteomics was founded in 2015.

Which sector is IQ Proteomics in?

IQ Proteomics operates in Life Sciences Technology.

Who are IQ Proteomics's competitors?

Companies similar to IQ Proteomics include PREEMIEr Diagnostics, Gattaca Genomics, and Healid.